Brief: Isofol Q1 Loss At SEK 47.9 Mln
May 12 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* ISOFOL MEDICAL AB (PUBL) PUBLISHES INTERIM REPORT,
JANUARY-MARCH
2022
* Q1 NET REVENUE AMOUNTED TO TSEK 4,006 (5,215) AND OTHER
REVENUE
TO TSEK 1 (0)
* Q1 RESULT FOR PERIOD AMOUNTED TO TSEK -47,874 (-42,662)
Source text for Eikon: ID:nWkr7ttfhz
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical reports no Q2 revenue, net loss widens
Brief: Isofol Medical Q2 Net Income SEK -15.729 Million
Brief: Isofol Medical Adds Clinical Trial Sites To Phase Ib/Ii Arfolitixorin Study In Colorectal Cancer
Sweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million